All Fostemsavir articles
-
NewsThe RESTART trial: a drug to block a toxic HIV molecule
What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never recover their health, even with antiretroviral treatment? Researchers will explore this in a groundbreaking clinical trial this fall.
-
NewsHIV: Thwarting a protein in the hope of a better quality of life
The sustained activation of the body’s immune system for people living with HIV leads to chronic inflammation that can cause associated complications such as cardiovascular diseases, osteoporosis or neurocognitive decline.